THENDURO
Live / Allowed — Notice of allowance issued (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99514239
- Mark type
- Word mark
- Filed
- 24 Nov 2025
- Published for opposition
- 28 Apr 2026
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, compounds for use in the treatment of urological fibrosis
- Class 042 — Scientific and technological services: Pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals for the treatment of diseases
Owner
- Thendor Therapeutics, Inc., Irvine, CA, US
- Thendor Therapeutics, Inc., Irvine, CA, US
Prosecution history
- 23 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2026 — PUBLISHED FOR OPPOSITION
- 22 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Nov 2025 — NEW APPLICATION ENTERED